We are live on ! Find out more
BAM

Bellevue Asset Management Portfolio holdings

AUM $217M
1-Year Est. Return 14.36%
This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+14.36%
3 Year Est. Return
+56.75%
5 Year Est. Return
+72.55%
10 Year Est. Return
–
AUM
$163M
AUM Growth
-$428K
Cap. Flow
-$9.43M
Cap. Flow %
-5.77%
Top 10 Hldgs %
57.97%
Holding
609
New
27
Increased
68
Reduced
90
Closed
31

Top Buys

Rank Stock Value
1
TSBK icon
Timberland Bancorp
TSBK
+$366K
2
LUV icon
Southwest Airlines
LUV
+$177K
3
F icon
Ford
F
+$140K
4
FNX icon
First Trust Mid Cap Core AlphaDEX Fund
FNX
+$120K
5
BABA icon
Alibaba
BABA
+$116K

Top Sells

Rank Stock Value
1
LMBS icon
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
+$7.07M
2
MSFT icon
Microsoft
MSFT
+$2.21M
3
INTC icon
Intel
INTC
+$271K
4
TSLA icon
Tesla
TSLA
+$152K
5
WRB icon
W.R. Berkley
WRB
+$148K

Sector Composition

Rank Sector Weight
1 Technology 36.03%
2 Consumer Discretionary 10.39%
3 Healthcare 5.07%
4 Consumer Staples 3.57%
5 Financials 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEN icon
526
Lennar Class A
LEN
$21.2B
$2K ﹤0.01%
24
– –
LUNG icon
527
Pulmonx
LUNG
$87.6M
$2K ﹤0.01%
48
– –
MCHP icon
528
Microchip Technology
MCHP
$46B
$2K ﹤0.01%
28
– –
MKL icon
529
Markel Group
MKL
$23.2B
$2K ﹤0.01%
2
– –
MTN icon
530
Vail Resorts
MTN
$5.3B
$2K ﹤0.01%
7
– –
LUXE
531
LuxExperience B.V.
LUXE
$1.11B
$2K ﹤0.01%
+64
New +$1.88K
NEOG icon
532
Neogen
NEOG
$2.5B
$2K ﹤0.01%
38
– –
NTLA icon
533
Intellia Therapeutics
NTLA
$1.67B
$2K ﹤0.01%
+14
New +$2.12K
PAY icon
534
Paymentus
PAY
$4.86B
$2K ﹤0.01%
+76
New +$2.15K
PEB icon
535
Pebblebrook Hotel Trust
PEB
$2.05B
$2K ﹤0.01%
110
– –
PRVA icon
536
Privia Health
PRVA
$2.87B
$2K ﹤0.01%
+67
New +$2.34K
QTWO icon
537
Q2 Holdings
QTWO
$3.92B
$2K ﹤0.01%
25
– –
RDFN
538
DELISTED
Redfin
RDFN
$2K ﹤0.01%
41
– –
SLAB icon
539
Silicon Laboratories
SLAB
$7.23B
$2K ﹤0.01%
17
– –
STRO icon
540
Sutro Biopharma
STRO
$421M
$2K ﹤0.01%
9
– –
TEVA icon
541
Teva Pharmaceuticals
TEVA
$41.2B
$2K ﹤0.01%
200
– –
TRU icon
542
TransUnion
TRU
$15.3B
$2K ﹤0.01%
17
– –
TWST icon
543
Twist Bioscience
TWST
$7.25B
$2K ﹤0.01%
15
– –
UP icon
544
Wheels Up
UP
$198M
$2K ﹤0.01%
1
– –
URBN icon
545
Urban Outfitters
URBN
$6.59B
$2K ﹤0.01%
50
– –
VRSK icon
546
Verisk Analytics
VRSK
$25B
$2K ﹤0.01%
8
– –
VRSN icon
547
VeriSign
VRSN
$26.6B
$2K ﹤0.01%
11
– –
NVRO
548
DELISTED
NEVRO CORP.
NVRO
$2K ﹤0.01%
19
– –
NARI
549
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2K ﹤0.01%
23
– –
DCPH
550
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2K ﹤0.01%
49
– –
20 21
22
23 24

Similar funds

CS
Capital Square Chattanooga, Tennessee $217M AUM 13.95% 1-Year Est. Return
MCM
M1 Capital Management Bloomfield Hills, Michigan $217M AUM 21.38% 1-Year Est. Return
EG
Enstar Group Hamilton, Bermuda $217M AUM 12.3% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
PPW
PACK Private Wealth Wayzata, Minnesota $218M AUM 19.98% 1-Year Est. Return
FAM
Fairtree Asset Management Bellville, Cape Town, South Africa $218M AUM 5.48% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
BFA
Bright Financial Advisors Portage, Michigan $218M AUM 17.53% 1-Year Est. Return

Bellevue Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Bellevue Asset Management held 609 positions worth $163M, down 0.26% from $164M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Bellevue Asset Management withdrew a net $9.43M in Q3 2021, closing 31 positions and reducing 90 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31K position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bellevue Asset Management opened a new position in Timberland Bancorp worth $371K.

  • Bellevue Asset Management's largest Q3 2021 buy was Timberland Bancorp: 12,800 shares worth $371K.
  • Bellevue Asset Management added most to Southwest Airlines in Q3 2021, an estimated $177K increase.
  • Bellevue Asset Management's biggest Q3 2021 reduction was First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF, cutting an estimated $7.07M.
  • Bellevue Asset Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31K.
  • Bellevue Asset Management's ten largest holdings make up 58% of its $163M portfolio in Q3 2021.
  • Bellevue Asset Management opened 27 new positions and closed 31 in Q3 2021.
  • Bellevue Asset Management's portfolio value fell 0.26% quarter-over-quarter to $163M.

Based on Bellevue Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.